LCN2 and acute kidney injury: For other commonly used biomarkers, such as serum and urine NGAL and cystatin C, as well as urine KIM-1 and L-FABP, the difference in markers levels were not significant between AKI Scr, AKI UO and no AKI over the first 3 days.